Results 201 to 210 of about 15,402 (239)

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection.

Blood
Visram A, Larson D, Norman A, Dispenzieri A, Murray D, Kyle R, Rajkumar SV, Slager S, Kumar S, Vachon C.   +9 more
europepmc   +1 more source

Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma. [PDF]

Clin Hematol Int
Patel TH, Bachu R, Shrivastava T, Alrawabdeh J, Alzubi M, Hastings J, Dean H, Schinke C, Thanendrarajan S, Zangari M, Tricot G, Zhan F, Shaughnessy JD, van Rhee F, Al Hadidi S.   +14 more
europepmc   +1 more source

Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome. [PDF]

Blood Cancer J
Giaccherini M, Clay-Gilmour AI, Liotti R, Macauda A, Gentiluomo M, Brown EE, Machiela MJ, Chanock SJ, Hildebrandt MAT, Norman AD, Manasanch E, Rajkumar SV, Hofmann JN, Berndt SI, Bhatti P, Giles GG, Ziv E, Kumar SK, Camp NJ, Cozen W, Slager SL, Canzian F, Gemignani F, Vachon CM, Campa D.   +24 more
europepmc   +1 more source

Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters

, 2019
Marcin Pasiarski, Barbara Sosnowska‐Pasiarska, Ewelina Grywalska, Agnieszka Stelmach-Gołdyś, Anna M Kowalik, Stanisław Góźdż, Jacek Roliński   +6 more
openalex   +1 more source

Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa. [PDF]

JNCI Cancer Spectr
Cicero KI, Dlamini X, Mavengere Y, Justman J, Nuwagaba-Biribonwoha H, Dlamini S, Dlamini M, Ngwenyama S, Ngcamphalala C, Low A, Philip NM, El-Sadr WM, Sahabo R, Abreha T, Temesgen S, Mahlalela N, Chiuzan C, Chen Y, Pan SS, Lentzsch S, Neugut AI.   +20 more
europepmc   +1 more source

Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance. [PDF]

Blood Cancer J
Zuern K, Hielscher T, Werly A, Breitkreutz I, Sauer S, Raab MS, Müller-Tidow C, Goldschmidt H, Mai EK.   +8 more
europepmc   +1 more source

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions. [PDF]

Pharmaceuticals (Basel)
Ferla V, Farina F, Perini T, Marcatti M, Ciceri F.   +4 more
europepmc   +1 more source

A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow-up. [PDF]

EJHaem
Anderson LD, Bladé J, Kyle RA.
europepmc   +1 more source

A rare case of crystalline deposits over Descemet’s membrane in a suspected case of monoclonal gammopathy of undetermined significance

TR Sharannya, Dipankar Das, Sangeeta Kalita, Gayatri Bharali, Harsha Bhattacharjee   +4 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Monoclonal Gammopathy of Undetermined Significance

Annals of Internal Medicine, 2022
Monoclonal gammopathy of undetermined significance (MGUS) is of considerable clinical importance to primary care physicians given its high prevalence in the general population. MGUS has a variable but lifelong risk for progression to hematologic cancer, such as multiple myeloma, Waldenström macroglobulinemia, or light-chain amyloidosis.
Wilson I. Gonsalves, S. Vincent Rajkumar
openaire   +2 more sources